ViaDerma Inc (VDRM)

[excelsiorvision]

Dubai is the middle east. Viaderma is wrapping up the stability testing requirements for Vitastem Ultra - the new bacitracin ingredient and not the old one for tetracycline that was supposed be sold there. Dubai might be back in play again once the stability requirements are met for the new product and sales can start up there too.

Dubai, Saudi Arabia, Bahrain, Qatar, Iraq, Iran, Yemen, Oman, etc. will all be in play for sales now.

The difference with all other nations aside from the US is they focus more on their citizens health and well-being. Healthcare costs are subsidized by their governments too. In the US, it's pay to play in healthcare. Most providers are incentivized to push prescription drugs on their patients and get big kick backs from pharma reps, while not providing more effective medicine like Vitastem even though it is much cheaper at the end of the day then all the other treatments.

I think this is why they are moving much faster overseas with deals than in the US. IMO.